Yongrui Bai

1.2k total citations
49 papers, 739 citations indexed

About

Yongrui Bai is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yongrui Bai has authored 49 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yongrui Bai's work include Esophageal Cancer Research and Treatment (8 papers), Cancer-related molecular mechanisms research (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Yongrui Bai is often cited by papers focused on Esophageal Cancer Research and Treatment (8 papers), Cancer-related molecular mechanisms research (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Yongrui Bai collaborates with scholars based in China, United States and Germany. Yongrui Bai's co-authors include Xiumei Ma, Ming Ye, Wen Xu, Weili Yan, Haiyan Chen, Xiaoxing Liu, Lei Xu, Gang Huang, Jianxin Gao and Tao Liu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yongrui Bai

45 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongrui Bai China 14 278 244 191 181 143 49 739
Liming Sheng China 15 480 1.7× 273 1.1× 191 1.0× 165 0.9× 146 1.0× 44 784
Elona Juozaitytė Lithuania 17 397 1.4× 143 0.6× 227 1.2× 169 0.9× 112 0.8× 86 842
Eleonora Pagan Italy 17 343 1.2× 192 0.8× 166 0.9× 182 1.0× 232 1.6× 48 936
Michelle Echevarria United States 9 253 0.9× 252 1.0× 117 0.6× 91 0.5× 89 0.6× 30 561
Thomas J. Semrad United States 15 395 1.4× 237 1.0× 122 0.6× 257 1.4× 162 1.1× 51 890
Hamid Raziee Canada 16 178 0.6× 291 1.2× 150 0.8× 195 1.1× 68 0.5× 40 646
Keith Unger United States 17 398 1.4× 373 1.5× 275 1.4× 107 0.6× 169 1.2× 64 940
Xiao-Jing Du China 8 497 1.8× 194 0.8× 145 0.8× 67 0.4× 60 0.4× 9 677
K. Park South Korea 13 664 2.4× 482 2.0× 201 1.1× 196 1.1× 98 0.7× 43 994
Qin Zhou China 13 128 0.5× 124 0.5× 91 0.5× 101 0.6× 80 0.6× 39 457

Countries citing papers authored by Yongrui Bai

Since Specialization
Citations

This map shows the geographic impact of Yongrui Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongrui Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongrui Bai more than expected).

Fields of papers citing papers by Yongrui Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongrui Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongrui Bai. The network helps show where Yongrui Bai may publish in the future.

Co-authorship network of co-authors of Yongrui Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Yongrui Bai. A scholar is included among the top collaborators of Yongrui Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongrui Bai. Yongrui Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lei, Jun Ma, Jun Zhang, et al.. (2025). Radiotherapy‐Associated Cellular Senescence and EMT Alterations Contribute to Distinct Disease Relapse Patterns in Locally Advanced Cervical Cancer. Advanced Science. 12(12). e2412574–e2412574. 4 indexed citations
2.
Zhang, You, et al.. (2025). CD70-Targeted [18F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study. Journal of Nuclear Medicine. 66(6). 865–872. 1 indexed citations
3.
Xu, Xin, Zhiyong Sun, Qiang Liu, et al.. (2024). Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer. Journal for ImmunoTherapy of Cancer. 12(3). e008631–e008631. 13 indexed citations
5.
Cai, Mei‐Chun, Di Jin, Tianxiang Zhang, et al.. (2024). Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder Cancer. Clinical Cancer Research. 30(21). 4920–4931. 1 indexed citations
6.
Wang, Xu An, et al.. (2024). Chinese national clinical practice guideline on diagnosis and treatment of biliary tract cancers. Chinese Medical Journal. 137(19). 2272–2293.
7.
Wang, Xiaohang, Xin Xu, Yuhui Huang, et al.. (2024). Predictive and prognostic value of ACSL4 and GPX4 in patients with esophageal squamous cell carcinoma receiving post-operative radiotherapy. Journal of Thoracic Disease. 16(12). 8317–8326.
9.
Gao, Jing, Yongrui Bai, Fei Miao, et al.. (2023). Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from 18F-FDG PET and MRI. Clinical Radiology. 78(10). 746–754. 4 indexed citations
10.
Wu, Zheng, Ying Lin, Limin Liu, et al.. (2022). Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis. Journal of Immunology Research. 2022. 1–11. 8 indexed citations
11.
Zhou, Jin, Haiping Lin, Xin Xu, et al.. (2022). The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy. Frontiers in Immunology. 13. 1041126–1041126. 10 indexed citations
12.
Xing, Xin, Yongrui Bai, & Jian Song. (2021). The Heterogeneity of Neutrophil Recruitment in the Tumor Microenvironment and the Formation of Premetastatic Niches. Journal of Immunology Research. 2021. 1–6. 7 indexed citations
13.
Wang, Tianwei, et al.. (2021). A retrospective analysis of the risk factors affecting recurrence time in patients with recurrent glioblastoma. Annals of Palliative Medicine. 10(13). 38–38. 10 indexed citations
14.
Wang, Tianwei, Binghong Chen, Keman Liao, et al.. (2021). A Novel Nomogram for Predicting the Risk of Short-Term Recurrence After Surgery in Glioma Patients. Frontiers in Oncology. 11. 740413–740413. 4 indexed citations
15.
Hu, Bin, Xiumei Ma, Zheng Wu, et al.. (2021). Identification of Key Genes Mutations Associated With the Radiosensitivity by Whole Exome Sequencing in Pancreatic Cancer. Frontiers in Oncology. 11. 697308–697308. 6 indexed citations
16.
Hou, Yanli, Bowen Sun, Wenxue Liu, et al.. (2020). Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling. Theranostics. 11(2). 555–566. 51 indexed citations
17.
Yan, Yi–Dan, Wenjuan Wang, Tao Xu, et al.. (2020). Drug-related problems among hospitalized cancer pain patients: an investigative single-arm intervention trial. Annals of Palliative Medicine. 10(2). 2008–2017. 13 indexed citations
18.
Bai, Yongrui, Yuejuan Xu, & Bin Wu. (2017). Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System. Gastroenterology Research and Practice. 2017. 1–7. 15 indexed citations
20.
Hou, Yanli, et al.. (2013). CT and MRI in target delineation in primary hepatocellular carcinoma. Cancer/Radiothérapie. 17(8). 750–754. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026